Status:
COMPLETED
Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment
Lead Sponsor:
EMS
Conditions:
Eczema
Eligibility:
All Genders
5-50 years
Phase:
PHASE3
Brief Summary
Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The propose of this tri...
Detailed Description
Study design: • Double blinded, superiority, prospective parallel-group, intend to treat trial. Study design: * Experiment duration: 22 days * 2 visits (days 1,7,15 and 22) * Reducing Eczema Area a...
Eligibility Criteria
Inclusion
- Patients must be able to understand the study procedures agree to participate and give written consent.
- Patients with acute or sub-acute eczema.
- Presence of symmetric lesions to compare on side to the other.
Exclusion
- Pregnancy or risk of pregnancy.
- Lactation
- Use of anti-inflammatory or immunosuppressive drugs (last 30 days prior to the study).
- Sunlight over exposure in the last 15 days.
- Any pathology or past medical condition that can interfere with this protocol.
Key Trial Info
Start Date :
September 6 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2013
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT01257061
Start Date
September 6 2012
End Date
August 2 2013
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medcin instituto da Pele
Osasco, São Paulo, Brazil, 060323-000